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Purpose 
Estimation of the frequency and spectrum of Neurogenic lower urinary tract dysfunction types in the Republic of Moldova. 
Material and methods  
A selective descriptive study based on F003/e of patients treated in IMSP Institute of Mother and Child (IMC) during the 
period 2017-2019 was performed. The selection criteria were the clinical diagnosis of: Uninhibited neuropathic bladder, not 
elsewhere classified (N31.0) or Reflex neuropathic bladder, not elsewhere classified (N31.1) or Flaccid neuropathic bladder, 
not elsewhere classified (N31.2). Based on these criteria, 478 patients were included in the study. 
Results 
Out of 478 patients, included in the study - 116 were 
hospitalized in 2017, 129 - in 2018 and 233 - in 2019. 
They represent from 10 to 18% of all urological patients 
hospitalized in the reference period. (fig. 1) 
Conclusions 
1. The frequency of Neurogenic lower urinary tract dysfunction in the Republic of Moldova is increasing (116 - in 
2017, 129 - in 2018 and 233 - in 2019) 
2.  Predominates reflex neuropathic bladder (57%), followed by flaccid neuropathic bladder (37%). 
 However, epidemiological studies are needed to establish the prevalence at the population level. 
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The diagnosis of uninhibited neuropathic bladder was 
present in 29 patients (6%), the reflex neuropathic 
bladder was established in 274 people (57%), the 
flaccid neuropathic bladder was diagnosed in 175 
patients (37%). (fig 2).  
Patients with uninhibited neuropathic bladder were 
hospitalized mainly in the Nephrology department (93%), 
but those with reflex neuropathic bladder and flaccid 
neuropathic bladder - in the Urology department (97.8% 
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Detailed distribution of NLUTD patterns for each year of 
the reference period of study is reflected in fig. 3. 
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Introduction  
Neurogenic lower urinary tract  dysfunction (NLUTD) is a dysfunction of the lower urinary tract secondary to confirmed 
pathology of the nervous system.¹ It represents  a heterogeneous entity, that may result from a variety of conditions affecting 
the central and peripheral nervous system.² The location and extent of the lesion in the neurological axis determines the 
general pattern of lower urinary tract (LUT) dysfunction, which is reflected in the patient’s symptoms.³ The comprehensive 
assessment of neurological patients reporting LUT symptoms involves a multidisciplinary team, including the treating 
neurologist, urologist, rehabilitation specialist, primary care physician, nurses and therapists.⁴ 
There are no exact data on the overall prevalence of neuro-urological disorders in the general population, but data are 
available on the prevalence of the underlying conditions and the relative risk of these for the development of neuro-urological 
symptoms.¹ In the Republic of Moldova there are no available data on the epidemiology of NLUTD. 
Figure 1. Proportion of patients with NLUTD in the general 
structure of urological patients, hospitalized in IMSP IMC 
Figure 2. Share of each type of dysfunction in the general 
structure of NLUTD in the period 2017-2019 
Figure 3. Proportion of each type of pathology in the general 
structure of patients with NLUTD in the IMSP IMC 
Figure 4. Distribution of patients by departments according to the 
type of NLUTD  
